Under 37 CFR § 1.14 United States Patent applications are preserved in confidence until published, which, by statue is 18 months from the priority date. All of our most sensitive data, new inventions and latest developments in artificial intelligence, engineering, healthcare and technology, safely housed within the USPTO without public access until access is granted […]
Continue Reading →Our U.S. Constitution, Article I Section 8, Clause 8, gives Congress the power to “promote the progress of science and the useful arts, by securing for limited times to authors and inventors the exclusive right to their respective writings and discoveries.” This is known as the Patent Clause of the Constitution. The executive order to […]
Continue Reading →On November 7, 2024, the World Intellectual Property Organization (WIPO) published is “Patents Highlights” for 2023, its most recent report on patent activity around the world. Patent application filings hit an all-time high of 3.5 million, an increase of 2.7% over 2022. This is the fourth consecutive annual increase, after a COVID decline of 3% […]
Continue Reading →On December 13, 2024, the European Patent Office President António Campinos welcomed a delegation from Costa Rica, led by the Minister of Justice and Peace Gerald Campos Valverde, for the signing of a landmark validation agreement. Costa Rica is the seventh country to sign a validation agreement with the EPO, following Morocco, Moldova, Tunisia, Cambodia, […]
Continue Reading →As we step into our 101st year of serving innovators, entrepreneurs, and visionaries at the intersection of technology and law, I find myself reflecting on what makes this milestone so meaningful. Throughout those hundred years, McKee, Voorhees & Sease (MVS), has continually evolved to meet new challenges, build lasting client relationships, and navigate the ever-shifting […]
Continue Reading →Samsung Electronics of the Republic of Korea received the honor of being the five millionth published PCT on November 29, 2024. This milestone for the Patent Cooperation Treaty – generally referred to as PCT – was 47 years in the making. It was also fitting that one of the largest patent filers receives notoriety and […]
Continue Reading →On December 19th, the FDA issued a FDA declaratory order noting the resolution of the shortage for tirzepatide injection products, including Mounjaro and Zepbound. The tirzepatide shortage, which began in December 2022, was driven by overwhelming demand for these breakthrough medications used in managing type 2 diabetes and obesity. The FDA’s most recent decision, effective […]
Continue Reading →As we approach the end of 2024, we hope you have had a successful and fulfilling year. I cannot help but think of what a milestone McKee, Voorhees & Sease had this year making it to our 100th anniversary, an achievement less than 1% of all law firms accomplish. We have exhibited snapshots of our […]
Continue Reading →In its final rule issued on November 20, 2024, the United States Patent and Trademark Office (USPTO) issued changes to set or increase certain patent fees. The revised fees will take effect on January 19, 2025. There will not be a new fee for After Final Consideration Pilot 2.0 requests as was proposed, nor will […]
Continue Reading →On November 18, 2024, the USPTO issued a final rule to increase certain trademark filing fees. The fees will take effect January 18, 2025. While the per Class fee for filing a standard electronic trademark application has not changed and is still $350 per Class, the USPTO has eliminated the distinction between TEAS Standard and […]
Continue Reading →Receive the latest news and updates from us and our attorneys.
Sign Up